NCT05046054

Brief Summary

Propofol, an intravenous sedative agent, frequently produces pain during injection. This study was designed to investigate whether transcutaneous electrical nerve stimulation could reduce pain during propofol injection. in minimizing propofol injection pain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 5, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 16, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2022

Completed
Last Updated

January 19, 2022

Status Verified

January 1, 2022

Enrollment Period

8 months

First QC Date

September 5, 2021

Last Update Submit

January 17, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • pain during propofol injection

    Propofol injection pain was evaluated by a study blinded anesthesiologist using a four point scale

    15 seconds

Study Arms (2)

transcutaneous electrical nerve stimulation group

ACTIVE COMPARATOR

Transcutaneous electrical nerve stimulation was givent via two electrodes on the venous cannulation site 20 min before propofol injection

Device: transcutaneous electrical nerve stimulation

control group

PLACEBO COMPARATOR

No transcutaneous electrical nerve stimulation was not given via two electrodes on the venous cannulation site 20 min before propofol injection

Device: Placebo transcutaneous electrical nerve stimulation

Interventions

transcutaneous electrical nerve stimulation group received transcutaneous electrical nerve stimulation via two electrodes on the venous cannulation site 20 min before propofol injection

transcutaneous electrical nerve stimulation group

Placebo transcutaneous electrical nerve stimulation group received no transcutaneous electrical nerve stimulation via two electrodes on the venous cannulation site 20 min before propofol injection

control group

Eligibility Criteria

Age19 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • American Society of Anesthesiologists physical status classification \> 3
  • Patient with a history of allergy to drugs
  • Patient who takes opioid, sedative, anticonvulsant
  • Patient with a history of neurologic disease and psychological disorders
  • patient with skin problem
  • Patient with pacemaker or electric medical device
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kyungpook National university hospital

Daegu, 41944, South Korea

RECRUITING

MeSH Terms

Conditions

Pain

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Officials

  • Younghoon Jeon

    Kyungpook National University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Younghoon Jeon, Dr

CONTACT

Younghoon Jeon

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Two electrodes were attached to the radial side of dominant forearm. In the placebo group the TENS device had no current output although the power "on" indicator light remained active.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: TENS YW-5000 (YoungWon Medical Co, Korea)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 5, 2021

First Posted

September 16, 2021

Study Start

June 1, 2021

Primary Completion

January 30, 2022

Study Completion

January 30, 2022

Last Updated

January 19, 2022

Record last verified: 2022-01

Locations